Key facts
- This page summarizes Stuart Walter Peltz's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Feb 2023, 15:22.
Stuart Walter Peltz - 31 Jan 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- PTCT
- Reported as of
- 31 Jan 2023
- Net transaction value
- -$119,591
- SEC form
- 4
- Accepted by SEC
- 02 Feb 2023, 15:22:42 UTC
- Prior SEC filing
- 26 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Avraham S. Adler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stuart Walter Peltz filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 02 Feb 2023.
Change
- Previous filing in this sequence was filed on 26 Jan 2023.
- Current net transaction value: -$119,591.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTCT
transaction
Common Stock
Sale
- Transaction value
- $105,857
- Shares
- -2,320
- Change %
- -1.4%
- Price
- $45.63
- Shares after
- 166,962
- Date
- 31 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
PTCT
transaction
Common Stock
Sale
- Transaction value
- $13,734
- Shares
- -301
- Change %
- -0.55%
- Price
- $45.63
- Shares after
- 54,903
- Date
- 31 Jan 2023
- Ownership
- By Spouse
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 8,250 RSUs from a January 29, 2020 grant of 33,000 RSUs.
Footnote F2
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,214 RSUs from a January 29, 2020 grant of 4,855 RSUs.